A simplified framework to optimize MRI contrast preparation.


Journal

Magnetic resonance in medicine
ISSN: 1522-2594
Titre abrégé: Magn Reson Med
Pays: United States
ID NLM: 8505245

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 04 10 2018
revised: 28 05 2018
accepted: 01 06 2018
pubmed: 29 9 2018
medline: 31 12 2019
entrez: 29 9 2018
Statut: ppublish

Résumé

This article proposes a rigorous optimal control framework for the design of preparation schemes that optimize MRI contrast based on relaxation time differences. Compared to previous optimal contrast preparation schemes, a drastic reduction of the optimization parameter number is performed. The preparation scheme is defined as a combination of several block pulses whose flip angles, phase terms and inter-pulse delays are optimized to control the magnetization evolution. The proposed approach reduces the computation time of This approach proposes key advances for the design of optimal contrast preparation sequences, that emphasize their ability to generate non-standard contrasts, their potential benefit in a clinical context, and their straightforward applicability on any MR system.

Identifiants

pubmed: 30265759
doi: 10.1002/mrm.27417
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

424-438

Subventions

Organisme : ANR-DFG Explosys
ID : ANR-14-CE35-0013-01
Pays : International
Organisme : ANR-DFG Explosys
ID : GL203/9-1
Pays : International
Organisme : TUM Institute for Advanced Study, the German Excellence Initiative, the E.U. Seventh Framework Programme
ID : 291763
Pays : International
Organisme : LABEX PRIMES
ID : ANR-11-LABX-0063
Pays : International
Organisme : LABEX PRIMES
ID : ANR-11-IDEX-0007
Pays : International

Informations de copyright

© 2018 International Society for Magnetic Resonance in Medicine.

Auteurs

Eric Van Reeth (EV)

CNRS, Inserm, CREATIS UMR 5220, U1206, Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France.

Hélène Ratiney (H)

CNRS, Inserm, CREATIS UMR 5220, U1206, Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France.

Kevin Tse Ve Koon (K)

CNRS, Inserm, CREATIS UMR 5220, U1206, Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France.

Michael Tesch (M)

Department of Chemistry, Technical University of Munich, Munich, Germany.

Denis Grenier (D)

CNRS, Inserm, CREATIS UMR 5220, U1206, Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France.

Olivier Beuf (O)

CNRS, Inserm, CREATIS UMR 5220, U1206, Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France.

Steffen J Glaser (SJ)

Department of Chemistry, Technical University of Munich, Munich, Germany.

Dominique Sugny (D)

ICB, CNRS UMR5209, Université de Bourgogne, France.
Institute for Advanced Study, Technical University of Munich, Garching, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH